Nanoparticle mediated silencing of DNA repair sensitizes pediatric brain tumor cells to γ-irradiation

Forrest M. Kievit, Zachary R. Stephen, Kui Wang, Christopher J. Dayringer, Jonathan G. Sham, Richard G. Ellenbogen, John R. Silber, Miqin Zhang

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Medulloblastoma (MB) and ependymoma (EP) are the most common pediatric brain tumors, afflicting 3000 children annually. Radiotherapy (RT) is an integral component in the treatment of these tumors; however, the improvement in survival is often accompanied by radiation-induced adverse developmental and psychosocial sequelae. Therefore, there is an urgent need to develop strategies that can increase the sensitivity of brain tumors cells to RT while sparing adjacent healthy brain tissue. Apurinic endonuclease 1 (Ape1), an enzyme in the base excision repair pathway, has been implicated in radiation resistance in cancer. Pharmacological and specificity limitations inherent to small molecule inhibitors of Ape1 have hindered their clinical development. Here we report on a nanoparticle (NP) based siRNA delivery vehicle for knocking down Ape1 expression and sensitizing pediatric brain tumor cells to RT. The NP comprises a superparamagnetic iron oxide core coated with a biocompatible, biodegradable coating of chitosan, polyethylene glycol (PEG), and polyethyleneimine (PEI) that is able to bind and protect siRNA from degradation and to deliver siRNA to the perinuclear region of target cells. NPs loaded with siRNA against Ape1 (NP:siApe1) knocked down Ape1 expression over 75% in MB and EP cells, and reduced Ape1 activity by 80%. This reduction in Ape1 activity correlated with increased DNA damage post-irradiation, which resulted in decreased cell survival in clonogenic assays. The sensitization was specific to therapies generating abasic lesions as evidenced by NP:siRNA not increasing sensitivity to paclitaxel, a microtubule disrupting agent. Our results indicate NP-mediated delivery of siApe1 is a promising strategy for circumventing pediatric brain tumor resistance to RT.

Original languageEnglish (US)
Pages (from-to)1071-1080
Number of pages10
JournalMolecular Oncology
Volume9
Issue number6
DOIs
StatePublished - Jun 1 2015

Fingerprint

DNA-(Apurinic or Apyrimidinic Site) Lyase
Brain Neoplasms
DNA Repair
Nanoparticles
Pediatrics
Small Interfering RNA
Radiotherapy
Ependymoma
Medulloblastoma
Radiation
Polyethyleneimine
Chitosan
Paclitaxel
Microtubules
DNA Damage
Neoplasms
Cell Survival
Pharmacology
Brain
Enzymes

Keywords

  • Ape1
  • Base excision repair
  • Ependymoma
  • Medulloblastoma
  • Nanomedicine
  • SiRNA

ASJC Scopus subject areas

  • Molecular Medicine
  • Genetics
  • Oncology
  • Cancer Research

Cite this

Kievit, F. M., Stephen, Z. R., Wang, K., Dayringer, C. J., Sham, J. G., Ellenbogen, R. G., ... Zhang, M. (2015). Nanoparticle mediated silencing of DNA repair sensitizes pediatric brain tumor cells to γ-irradiation. Molecular Oncology, 9(6), 1071-1080. https://doi.org/10.1016/j.molonc.2015.01.006

Nanoparticle mediated silencing of DNA repair sensitizes pediatric brain tumor cells to γ-irradiation. / Kievit, Forrest M.; Stephen, Zachary R.; Wang, Kui; Dayringer, Christopher J.; Sham, Jonathan G.; Ellenbogen, Richard G.; Silber, John R.; Zhang, Miqin.

In: Molecular Oncology, Vol. 9, No. 6, 01.06.2015, p. 1071-1080.

Research output: Contribution to journalArticle

Kievit, FM, Stephen, ZR, Wang, K, Dayringer, CJ, Sham, JG, Ellenbogen, RG, Silber, JR & Zhang, M 2015, 'Nanoparticle mediated silencing of DNA repair sensitizes pediatric brain tumor cells to γ-irradiation', Molecular Oncology, vol. 9, no. 6, pp. 1071-1080. https://doi.org/10.1016/j.molonc.2015.01.006
Kievit, Forrest M. ; Stephen, Zachary R. ; Wang, Kui ; Dayringer, Christopher J. ; Sham, Jonathan G. ; Ellenbogen, Richard G. ; Silber, John R. ; Zhang, Miqin. / Nanoparticle mediated silencing of DNA repair sensitizes pediatric brain tumor cells to γ-irradiation. In: Molecular Oncology. 2015 ; Vol. 9, No. 6. pp. 1071-1080.
@article{222cf40b2e35450ebcc1995d002ba86b,
title = "Nanoparticle mediated silencing of DNA repair sensitizes pediatric brain tumor cells to γ-irradiation",
abstract = "Medulloblastoma (MB) and ependymoma (EP) are the most common pediatric brain tumors, afflicting 3000 children annually. Radiotherapy (RT) is an integral component in the treatment of these tumors; however, the improvement in survival is often accompanied by radiation-induced adverse developmental and psychosocial sequelae. Therefore, there is an urgent need to develop strategies that can increase the sensitivity of brain tumors cells to RT while sparing adjacent healthy brain tissue. Apurinic endonuclease 1 (Ape1), an enzyme in the base excision repair pathway, has been implicated in radiation resistance in cancer. Pharmacological and specificity limitations inherent to small molecule inhibitors of Ape1 have hindered their clinical development. Here we report on a nanoparticle (NP) based siRNA delivery vehicle for knocking down Ape1 expression and sensitizing pediatric brain tumor cells to RT. The NP comprises a superparamagnetic iron oxide core coated with a biocompatible, biodegradable coating of chitosan, polyethylene glycol (PEG), and polyethyleneimine (PEI) that is able to bind and protect siRNA from degradation and to deliver siRNA to the perinuclear region of target cells. NPs loaded with siRNA against Ape1 (NP:siApe1) knocked down Ape1 expression over 75{\%} in MB and EP cells, and reduced Ape1 activity by 80{\%}. This reduction in Ape1 activity correlated with increased DNA damage post-irradiation, which resulted in decreased cell survival in clonogenic assays. The sensitization was specific to therapies generating abasic lesions as evidenced by NP:siRNA not increasing sensitivity to paclitaxel, a microtubule disrupting agent. Our results indicate NP-mediated delivery of siApe1 is a promising strategy for circumventing pediatric brain tumor resistance to RT.",
keywords = "Ape1, Base excision repair, Ependymoma, Medulloblastoma, Nanomedicine, SiRNA",
author = "Kievit, {Forrest M.} and Stephen, {Zachary R.} and Kui Wang and Dayringer, {Christopher J.} and Sham, {Jonathan G.} and Ellenbogen, {Richard G.} and Silber, {John R.} and Miqin Zhang",
year = "2015",
month = "6",
day = "1",
doi = "10.1016/j.molonc.2015.01.006",
language = "English (US)",
volume = "9",
pages = "1071--1080",
journal = "Molecular Oncology",
issn = "1574-7891",
publisher = "Elsevier",
number = "6",

}

TY - JOUR

T1 - Nanoparticle mediated silencing of DNA repair sensitizes pediatric brain tumor cells to γ-irradiation

AU - Kievit, Forrest M.

AU - Stephen, Zachary R.

AU - Wang, Kui

AU - Dayringer, Christopher J.

AU - Sham, Jonathan G.

AU - Ellenbogen, Richard G.

AU - Silber, John R.

AU - Zhang, Miqin

PY - 2015/6/1

Y1 - 2015/6/1

N2 - Medulloblastoma (MB) and ependymoma (EP) are the most common pediatric brain tumors, afflicting 3000 children annually. Radiotherapy (RT) is an integral component in the treatment of these tumors; however, the improvement in survival is often accompanied by radiation-induced adverse developmental and psychosocial sequelae. Therefore, there is an urgent need to develop strategies that can increase the sensitivity of brain tumors cells to RT while sparing adjacent healthy brain tissue. Apurinic endonuclease 1 (Ape1), an enzyme in the base excision repair pathway, has been implicated in radiation resistance in cancer. Pharmacological and specificity limitations inherent to small molecule inhibitors of Ape1 have hindered their clinical development. Here we report on a nanoparticle (NP) based siRNA delivery vehicle for knocking down Ape1 expression and sensitizing pediatric brain tumor cells to RT. The NP comprises a superparamagnetic iron oxide core coated with a biocompatible, biodegradable coating of chitosan, polyethylene glycol (PEG), and polyethyleneimine (PEI) that is able to bind and protect siRNA from degradation and to deliver siRNA to the perinuclear region of target cells. NPs loaded with siRNA against Ape1 (NP:siApe1) knocked down Ape1 expression over 75% in MB and EP cells, and reduced Ape1 activity by 80%. This reduction in Ape1 activity correlated with increased DNA damage post-irradiation, which resulted in decreased cell survival in clonogenic assays. The sensitization was specific to therapies generating abasic lesions as evidenced by NP:siRNA not increasing sensitivity to paclitaxel, a microtubule disrupting agent. Our results indicate NP-mediated delivery of siApe1 is a promising strategy for circumventing pediatric brain tumor resistance to RT.

AB - Medulloblastoma (MB) and ependymoma (EP) are the most common pediatric brain tumors, afflicting 3000 children annually. Radiotherapy (RT) is an integral component in the treatment of these tumors; however, the improvement in survival is often accompanied by radiation-induced adverse developmental and psychosocial sequelae. Therefore, there is an urgent need to develop strategies that can increase the sensitivity of brain tumors cells to RT while sparing adjacent healthy brain tissue. Apurinic endonuclease 1 (Ape1), an enzyme in the base excision repair pathway, has been implicated in radiation resistance in cancer. Pharmacological and specificity limitations inherent to small molecule inhibitors of Ape1 have hindered their clinical development. Here we report on a nanoparticle (NP) based siRNA delivery vehicle for knocking down Ape1 expression and sensitizing pediatric brain tumor cells to RT. The NP comprises a superparamagnetic iron oxide core coated with a biocompatible, biodegradable coating of chitosan, polyethylene glycol (PEG), and polyethyleneimine (PEI) that is able to bind and protect siRNA from degradation and to deliver siRNA to the perinuclear region of target cells. NPs loaded with siRNA against Ape1 (NP:siApe1) knocked down Ape1 expression over 75% in MB and EP cells, and reduced Ape1 activity by 80%. This reduction in Ape1 activity correlated with increased DNA damage post-irradiation, which resulted in decreased cell survival in clonogenic assays. The sensitization was specific to therapies generating abasic lesions as evidenced by NP:siRNA not increasing sensitivity to paclitaxel, a microtubule disrupting agent. Our results indicate NP-mediated delivery of siApe1 is a promising strategy for circumventing pediatric brain tumor resistance to RT.

KW - Ape1

KW - Base excision repair

KW - Ependymoma

KW - Medulloblastoma

KW - Nanomedicine

KW - SiRNA

UR - http://www.scopus.com/inward/record.url?scp=84929517261&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84929517261&partnerID=8YFLogxK

U2 - 10.1016/j.molonc.2015.01.006

DO - 10.1016/j.molonc.2015.01.006

M3 - Article

C2 - 25681012

AN - SCOPUS:84929517261

VL - 9

SP - 1071

EP - 1080

JO - Molecular Oncology

JF - Molecular Oncology

SN - 1574-7891

IS - 6

ER -